This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hahnloser, D. Articles by Thibodeau, S. N. Search for Related Content PubMed PubMed Citation Articles by Hahnloser, D. Articles by Thibodeau, S. N.

The APC E1317Q Variant in Adenomatous Polyps and Colorectal Cancers¹

Division of Colon and Rectal Surgery [D. H.] and Departments of Health Science Research [G. M. P., K. R.], Medical Genetics [K. S., N. M. L.], Gastroenterology [L. B.], and Laboratory Medicine and Pathology [D. H., B. K., D. D., L. W., K. S., S. N. T.], Mayo Clinic, Rochester, Minnesota 55905

Genetic susceptibility may play a role in many colorectal cancers (CRCs). Known syndromes such as familial adenomatous polyposis and hereditary nonpolyposis CRC account for <5% of CRCs. The germ-line missense variant of the APC gene, E1317Q, has been proposed to confer a risk for colonic adenomatous polyps (adenomas), but not for CRCs in the general population. These findings are contradictory and controversial. In the present study, 608 cases (377 patients with CRC, 145 patients with 4–100 lifetime adenomas, and 86 with 3 lifetime adenomas), and 679 controls (362 spouses and 317 patients with normal colonoscopy) were screened for the APC E1317Q variant. The frequency of heterozygotes for E1317Q among patients with CRC (2.4%), patients with 4–100 adenomas (1.4%), and 3 adenomas (3.5%) did not differ from spouse controls (2.8%). When CRC patients were examined by DNA mismatch repair status, age at onset (age 50 versus >50), or family history of CRC, no differences in the frequency of E1317Q were found. The APC variant E1317Q does not appear to be associated with increased risk for colorectal neoplasia in the general population. However, when we used normal colonoscopy controls (E1317Q carrier frequency = 0.3%), the prevalence of E1317Q was significantly increased in CRC patients, in patients with 3 adenomas, and in CRC patients with intact mismatch repair status, suggesting a possible role for E1317Q in colorectal tumorigenesis. These results underscore the importance of carefully defining the controls to be used in comparisons of allele frequencies.

This article has been cited by other articles:

				D. Azzopardi, A. R. Dallosso, K. Eliason, B. C. Hendrickson, N. Jones, E. Rawstorne, J. Colley, V. Moskvina, C. Frye, J. R. Sampson, et al. Multiple Rare Nonsynonymous Variants in the Adenomatous Polyposis Coli Gene Predispose to Colorectal Adenomas Cancer Res., January 15, 2008; 68(2): 358 - 363. [Abstract] [Full Text] [PDF]

				L. S. Rozek, G. Rennert, and S. B. Gruber APC E1317Q Is Not Associated with Colorectal Cancer in a Population-Based Case-Control Study in Northern Israel. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2325 - 2327. [Abstract] [Full Text] [PDF]

				Z. Kemp, C. Thirlwell, O. Sieber, A. Silver, and I. Tomlinson An update on the genetics of colorectal cancer Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R177 - R185. [Abstract] [Full Text] [PDF]